Indefinite Delivery Contract 36C26024D0036

Award Date 9/9/24
Last Date to Order 9/8/29
Awardee
Cepheid
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This federal contract IDV award from the U.S. Department of Veterans Affairs (VA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, aims to procure a range of laboratory supplies, including diagnostic testing equipment, reagents, consumables, and associated maintenance and support services. The IDV, which has a total ceiling value of $7,489,000 and a period of performance through September 30, 2029, does not utilize any set-aside designations. The task orders issued...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) between the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 16 and Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract has a ceiling value of $3,426,923.40 and a period of performance extending to June 30, 2029. Under this IDC, Cepheid will provide the VA with a reagent lease for its molecular diagnostic testing equipment and associated...
This federal contract IDV award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, is for the provision of CEPHEID REAGENTS AND SUPPLIES to the Department of Veterans Affairs (VA) Veterans Integrated Service Network 17. The contract has a total ceiling value of $1,931,026.75 and a period of performance through April 2026. The contract consists of multiple firm fixed-price delivery orders issued to Cepheid to supply its GeneXpert diagnostic systems, molecular reagents,...
The federal contract IDV award is held by Cepheid, a for-profit manufacturer of molecular diagnostic solutions including tests for infectious diseases and genetic conditions. The contract, valued at a ceiling of $14,608,507.24, is with the Department of Veterans Affairs (VA) Veterans Integrated Service Network 8 for the procurement of Cepheid reagents and test kits. This single-award indefinite delivery contract enables the VA to continuously obtain Cepheid's molecular diagnostic products to...
This federal contract IDV award from the Department of Veterans Affairs (VA) Veterans Integrated Service Network 4 (VISN 4) is for the procurement of TEST KITS from Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The IDV has a ceiling value of $4,115,434.10 and a period of performance through September 20, 2029. Cepheid, as the prime contractor, has been awarded multiple delivery orders under this IDV ranging from $24,211.35 to $615,490.54 for the provision of test kits...
The U.S. Department of Veterans Affairs (VA) awarded a $1,327,941.46 firm fixed-price delivery order contract to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions, under an Indefinite Delivery Vehicle (IDV) contract. The contract is for the lease of molecular analyzers and cost-per-test services. Cepheid specializes in advanced diagnostic systems and test kits for infectious diseases, genetic conditions, and clinical testing, providing comprehensive molecular diagnostic...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) granted by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 17 to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The $1,434,421.04 contract is for the lease and supply of GeneXpert diagnostic equipment, reagents, consumables, and maintenance services to support clinical testing programs serving veterans. The contract does not have a set-aside designation....
This federal Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 20, a civilian agency, to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract has a ceiling value of $2,200,000 and a period of performance ending on August 31, 2029. Under this single-award IDC, Cepheid will provide the VA with reagents and consumables for laboratory tests. The contract includes a specific Firm Fixed Price...
The U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 8 awarded a single-award indefinite delivery contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to procure reagents and test kits for the VA's GeneXpert diagnostic systems. The $3,783,614.55 delivery order contract has a performance period through March 31, 2025. Cepheid, as the original equipment manufacturer, will provide the VA with the necessary diagnostic consumables to support...
The federal contract IDV award is a Blanket Purchase Agreement (BPA) master contract between the Defense Health Agency (DHA) and Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract has a ceiling value of $8,000,000 and an ultimate completion date of January 24, 2030. Under this single-award BPA, Cepheid provides the DHA with reagents, testing kits, and consumable supplies for molecular diagnostic testing. Key products include GeneXpert diagnostic systems,...
  • 36C26024D0036
    Indefinite Delivery Contract
  • 1
    Federal Contract Awards

This federal contract IDV was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 20 (VISN 20) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The single-award IDV has a ceiling value of $4,300,000 and an ultimate completion date of September 8, 2029.

Under this IDV, a $779,868.80 firm-fixed-price delivery order was issued to Cepheid for the provision of reagents and consumables for laboratory testing, with a period of performance ending on September 8, 2025. Cepheid is an experienced federal contractor, holding several IDVs with the VA for the procurement of its molecular diagnostic solutions, including GeneXpert test kits and equipment, to support clinical testing programs serving veterans. The company has also participated as a subrecipient on federal grants, collaborating with academic partners to improve tuberculosis diagnostics globally.

Generated 9/17/24, 9:05 AM